Pathology Asia Holdings
News,Singapore,Investments,Asia,HealthTech
Mayo Clinic Laboratories invests in Pathology Asia and LifeStrands Genomics
Mayo Clinic Laboratories has invested in Singapore-based Pathology Asia Holdings and LifeStrands Genomics to expand advanced diagnostics and precision medicine across Asia Pacific.
September 23, 2026
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026




